Morgan Stanley reduced its McKesson Corporation MCK from Overweight to Equal-weight
Morgan Stanley commented, "We estimate flattish EBIT growth in CY13 due to lower new exclusive generics and see EPS growth driven by capital deployment vs. operations. With no NT catalyst and premium EV/EBITDA multiple vs. peers & historical average on our below consensus EBIT estimate, share upside looks limited."
McKesson Corporatio closed at $88.67 on Thursday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in